{
    "info": {
        "nct_id": "NCT03206177",
        "official_title": "Feasibility IB Trial of Paclitaxel/Carboplatin + Galunisertib (a Small Molecule Inhibitor of the Kinase Domain of Type 1 TGF-B Receptor) in Patients With Newly Diagnosed, Persistent or Recurrent Carcinosarcoma of the Uterus or Ovary",
        "inclusion_criteria": "1. Women ≥ 18 years old with a diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma, for whom treatment with combination paclitaxel and carboplatin is recommended.\n2. Written informed consent/assent prior to any study-specific procedures\n3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n4. Tissue available for translational study (paraffin block or new biopsy) .\n5. Adequate bone marrow, renal, and hepatic function as defined per protocol.\n6. No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.\n7. Ability to swallow tablets\n8. For Women of child-bearing potential:Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib. Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug.\n9. Patient must have measurable disease before the treatment\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
        "exclusion_criteria": "1. Planned radiotherapy during or after the study chemotherapy prior to disease progression.\n2. Receipt of chemotherapy or radiation within 28 days of study treatment\n3. Have had a major surgical procedure or a significant traumatic injury within 28 days prior to study treatment; Minor procedures such as biopsy within 7 days prior to study treatment are allowed.\n4. Active infection that would preclude receipt of chemotherapy\n5. Moderate or severe cardiovascular disease per protocol\n6. Active pregnancy or lactation\n7. Second primary malignancy for which treatment during the study period would be recommended if this cancer were not also present.\n8. Prior malignancy requiring treatment within the last 3 years\n9. Use of another investigational product or device within 4 weeks of study entry or during study participation.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have maximum age of 99 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 99 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 99,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Tissue available for translational study (paraffin block or new biopsy) .",
            "criterions": [
                {
                    "exact_snippets": "Tissue available for translational study (paraffin block or new biopsy)",
                    "criterion": "tissue for translational study",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "paraffin block",
                                "new biopsy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Written informed consent/assent prior to any study-specific procedures",
            "criterions": [
                {
                    "exact_snippets": "Written informed consent/assent prior to any study-specific procedures",
                    "criterion": "informed consent/assent",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": "written"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to any study-specific procedures"
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Patient must have measurable disease before the treatment",
            "criterions": [
                {
                    "exact_snippets": "Patient must have measurable disease before the treatment",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "before the treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Adequate bone marrow, renal, and hepatic function as defined per protocol.",
            "criterions": [
                {
                    "exact_snippets": "Adequate bone marrow ... function",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... renal ... function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... hepatic function",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.",
            "criterions": [
                {
                    "exact_snippets": "No disease-modifying therapy, including investigational treatments, within 28 days prior to initiation of study treatment.",
                    "criterion": "disease-modifying therapy",
                    "requirements": [
                        {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "No ... investigational treatments, within 28 days prior to initiation of study treatment.",
                    "criterion": "investigational treatments",
                    "requirements": [
                        {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": {
                                "operator": "<",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. For Women of child-bearing potential:Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib. Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug.",
            "criterions": [
                {
                    "exact_snippets": "Women of child-bearing potential",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive_potential",
                            "expected_value": "of child-bearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "Willingness to use a highly effective method of contraception during the study and for 6 months following the last dose of galunisertib",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "method",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "during the study and for 6 months following the last dose of galunisertib"
                        }
                    ]
                },
                {
                    "exact_snippets": "Negative beta human chorionic gonadotropin pregnancy test documented within 7 days prior to initiation of study drug",
                    "criterion": "pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "test_type",
                            "expected_value": "beta human chorionic gonadotropin"
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "within 7 days prior to initiation of study drug"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Women ≥ 18 years old with a diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma, for whom treatment with combination paclitaxel and carboplatin is recommended.",
            "criterions": [
                {
                    "exact_snippets": "Women",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "≥ 18 years old",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "diagnosis of primary, recurrent or progressive uterine, ovarian, fallopian tube or peritoneal carcinosarcoma",
                    "criterion": "carcinosarcoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_status",
                            "expected_value": [
                                "primary",
                                "recurrent",
                                "progressive"
                            ]
                        },
                        {
                            "requirement_type": "anatomic_site",
                            "expected_value": [
                                "uterine",
                                "ovarian",
                                "fallopian tube",
                                "peritoneal"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "for whom treatment with combination paclitaxel and carboplatin is recommended",
                    "criterion": "treatment recommendation",
                    "requirements": [
                        {
                            "requirement_type": "treatment_recommendation",
                            "expected_value": "combination paclitaxel and carboplatin"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Ability to swallow tablets",
            "criterions": [
                {
                    "exact_snippets": "Ability to swallow tablets",
                    "criterion": "ability to swallow tablets",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "7. Second primary malignancy for which treatment during the study period would be recommended if this cancer were not also present.",
            "criterions": [
                {
                    "exact_snippets": "Second primary malignancy",
                    "criterion": "second primary malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for which treatment during the study period would be recommended if this cancer were not also present",
                    "criterion": "need for treatment of second primary malignancy during the study period",
                    "requirements": [
                        {
                            "requirement_type": "treatment recommendation during study period if index cancer not present",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Active infection that would preclude receipt of chemotherapy",
            "criterions": [
                {
                    "exact_snippets": "Active infection that would preclude receipt of chemotherapy",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "sufficient to preclude receipt of chemotherapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Prior malignancy requiring treatment within the last 3 years",
            "criterions": [
                {
                    "exact_snippets": "Prior malignancy requiring treatment within the last 3 years",
                    "criterion": "prior malignancy",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Have had a major surgical procedure or a significant traumatic injury within 28 days prior to study treatment; Minor procedures such as biopsy within 7 days prior to study treatment are allowed.",
            "criterions": [
                {
                    "exact_snippets": "Have had a major surgical procedure ... within 28 days prior to study treatment",
                    "criterion": "major surgical procedure",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "significant traumatic injury within 28 days prior to study treatment",
                    "criterion": "significant traumatic injury",
                    "requirements": [
                        {
                            "requirement_type": "time since injury",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Minor procedures such as biopsy within 7 days prior to study treatment are allowed",
                    "criterion": "minor procedures (such as biopsy)",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Use of another investigational product or device within 4 weeks of study entry or during study participation.",
            "criterions": [
                {
                    "exact_snippets": "Use of another investigational product or device within 4 weeks of study entry",
                    "criterion": "use of another investigational product or device",
                    "requirements": [
                        {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Use of another investigational product or device ... during study participation",
                    "criterion": "use of another investigational product or device",
                    "requirements": [
                        {
                            "requirement_type": "use during study participation",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Active pregnancy or lactation",
            "criterions": [
                {
                    "exact_snippets": "Active pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "lactation",
                    "criterion": "lactation",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Planned radiotherapy during or after the study chemotherapy prior to disease progression.",
            "criterions": [
                {
                    "exact_snippets": "Planned radiotherapy during or after the study chemotherapy prior to disease progression.",
                    "criterion": "planned radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": [
                                "during the study chemotherapy",
                                "after the study chemotherapy"
                            ]
                        },
                        {
                            "requirement_type": "before disease progression",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Moderate or severe cardiovascular disease per protocol",
            "criterions": [
                {
                    "exact_snippets": "Moderate or severe cardiovascular disease",
                    "criterion": "cardiovascular disease",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Receipt of chemotherapy or radiation within 28 days of study treatment",
            "criterions": [
                {
                    "exact_snippets": "Receipt of chemotherapy ... within 28 days of study treatment",
                    "criterion": "chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Receipt of ... radiation within 28 days of study treatment",
                    "criterion": "radiation",
                    "requirements": [
                        {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}